| Keywords: |
genetics; clinical feature; review; cancer risk; nuclear magnetic resonance imaging; paraganglioma; genetic association; genetic variability; practice guideline; renal cell carcinoma; kidney neoplasms; kidney tumor; carcinoma, renal cell; early cancer; family history; von hippel-lindau; birt hogg dube syndrome; genetic risk; von hippel lindau disease; pheochromocytoma; genetic predisposition; genetic screening; onset age; cowden syndrome; tuberous sclerosis; genetic testing; fumarate hydratase; neoplastic syndromes, hereditary; humans; human; hereditary tumor syndrome; hereditary leiomyomatosis and renal cell carcinoma; familial renal cell carcinoma; bap1-tumor predisposition syndrome; birt–hogg–dubé; hereditary renal cell carcinoma
|
